Career in mRNA–Lipid Nanoparticle Research: Translating Discovery into Drug Development

Event Information

Event Date

October 31, 2025

USA Time

08:00 AM PST

Canada Time

11:00 am (EDT)

Bangladesh Time

09:00 pm (GMT+6)

Location

Teams Online

Speaker Name

Dr. Md. Emranul Karim

Organizer

Talent Tweak

Registration Fee

Free

Event Description

This session is part of the Talent Tweak’s Life Science Career Webinar Series, an initiative that brings together life scientists from diverse fields to share their experiences, insights, and career journeys. Each session highlights a unique area of biomedical research—bridging science, innovation, and professional growth—to inspire and guide early-career researchers around the world.

In this session, we explore how mRNA–Lipid Nanoparticle (LNP) platforms are shaping the future of modern therapeutics and drug development. Designed for students and young researchers, the webinar focuses on the scientific foundation, translational potential, and evolving career opportunities within this fast-growing area of research.

Presented by:

Dr. Md. Emranul Karim is a Visiting Postdoctoral Scholar in the Department of Medicine, Division of Infectious Diseases & Geographic Medicine at Stanford University

In this interactive session, you will:

  • Understand how mRNA–Lipid Nanoparticle (LNP) platforms are transforming modern drug development and therapeutic innovation.
  • Explore key research roles and career pathways within mRNA technology, nanomedicine, and translational science.
  • Learn from the speaker’s experience how discoveries progress from molecular design to clinical application through collaborative preclinical and translational research.
  • Gain practical insights—drawn from real-world experience—into the technical expertise, interdisciplinary collaboration, and professional skills that drive success in this rapidly evolving field.

Who should attend?

Undergraduate, graduate students, Post-docs, early-career researchers, and anyone aspiring to pursue a research career globally

Webinar Rules & Regulations

  • This webinar is a 1 hour and 30 minute session, beginning with a brief 5-minute overview of the rules and an introduction to the speaker.
  • The session will consist of a presentation by the guest speaker, followed by an interactive Q&A segment
  • Registration is required. All registered participants will receive the webinar access link 48 hours before the event.
  • Participants may submit questions during the session, which will be addressed during the Q&A period.
  • The webinar is conducted strictly for educational purposes and is not intended for commercial promotion.
  • A recorded and edited version of the session may later be uploaded to the Talent Tweak platform for educational use.

Speaker Bio

MD Emranul KarimDr. Md. Emranul Karim is a Visiting Postdoctoral Scholar in the Department of Medicine, Division of Infectious Diseases & Geographic Medicine at Stanford University, working in the laboratory of Prof. Paul Bollyky. His current research focuses on RNA therapeutics and innovative delivery strategies for infectious, immune-mediated diseases, and cancer.

Before joining Stanford, Dr. Karim was a Postdoctoral Associate in the Department of Chemical Engineering at the Massachusetts Institute of Technology (MIT), where he worked with Prof. Allan S. Myerson on developing continuous manufacturing platforms for in vitro transcription (IVT) of messenger RNA. His training at MIT provided expertise in mRNA synthesis, process optimization, and scalable manufacturing.

Dr. Karim’s broader research background lies in nanoparticle-based drug delivery and translational nanomedicine. He has extensive experience in the design and characterization of lipid nanoparticles (LNPs) and hybrid nanocarriers for nucleic acid delivery, with applications in vaccines, oncology, and regenerative medicine. He earned his Ph.D. in Biomedical Sciences from Monash University, where he developed novel nanoparticle platforms for targeted drug and gene delivery to breast cancer.

His long-term vision is to bridge RNA manufacturing and next-generation delivery technologies to accelerate the clinical translation of nucleic acid–based medicines.